SCHEMBL329004

SCHEMBL329004

CCCCCCc1c(CCCC)sc(CCCC)c1CCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
GPR35 Q9HC97 5/20 0.37
TYMP P19971 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ESR1 P03372 2/20 0.34
ADRA2A P08913 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
TACR2 P21452 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
PTGS2 P35354 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
SHBG P04278 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSPD1 P10809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL991441 0.98 ALDH1A1 (0.41) ALDH1A1TSHRTHRBGPR35TYMP
SCHEMBL12704406 0.80 GPR35 (0.37) ALDH1A1TSHRTHRBGPR35TYMP
SCHEMBL12874162 0.80 GPR35 (0.37) ALDH1A1TSHRTHRBGPR35TYMP
SCHEMBL15477357 0.80 SCD (0.49) ALDH1A1TSHRESR1HSD17B10
SCHEMBL5683540 0.80 SCD (0.49) ALDH1A1TSHRESR1HSD17B10
SCHEMBL5784377 0.77 NPC1 (0.32) NPSR1NPC1HPGDMAPK1HTT
SCHEMBL8389921 0.77 NPC1 (0.36) TYMPNPSR1KDM4ENPC1HPGD
SCHEMBL17353542 0.77 GPR35 (0.56) ALDH1A1GPR35
SCHEMBL17008157 0.76 TSHR (0.57) ALDH1A1TSHRTHRBTYMPESR1
SCHEMBL9347762 0.76 GPR35 (0.35) ALDH1A1GPR35TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378338-B2 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-02-19 US disclosed
EP-2520572-A1 Nitrogen-containing fused-ring compound, polymer comprising a nitrogen-containing fused-ring repeating unit, organic thin film, and organic thin film element SUMITOMO CHEMICAL CO., LTD. (JP) 2012-11-07 EP disclosed
US-20120049174-A1 CONJUGATED COMPOUND, AND ORGANIC THIN FILM AND ORGANIC THIN FILM ELEMENT EACH COMPRISING SAME OSAKA UNIVERSITY (JP) 2012-03-01 US disclosed
EP-2407465-A1 CONJUGATED COMPOUND, AND ORGANIC THIN FILM AND ORGANIC THIN FILM ELEMENT EACH COMPRISING SAME Sumitomo Chemical Company, Limited (JP) 2012-01-18 EP disclosed
US-20100301314-A1 CONJUGATED COMPOUND, NITROGENATED CONDENSED-RING COMPOUND, NITROGENATED CONDENSED-RING POLYMER, ORGANIC THIN FILM, AND ORGANIC THIN FILM ELEMENT OSAKA UNIVERSITY (JP) 2010-12-02 US disclosed
EP-2223918-A1 CONJUGATED COMPOUND, NITROGENATED CONDENSED-RING COMPOUND, NITROGENATED CONDENSED-RING POLYMER, ORGANIC THIN FILM, AND ORGANIC THIN FILM ELEMENT Osaka University (JP) 2010-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049174-A1 CONJUGATED COMPOUND, AND ORGANIC THIN FILM AND ORGANIC THIN FILM ELEMENT EACH COMPRISING SAME AHR, C9, C5 ALDH1A1 1342/4885TSHR 582/4885THRB 1066/4885
US-20100301314-A1 CONJUGATED COMPOUND, NITROGENATED CONDENSED-RING COMPOUND, NITROGENATED CONDENSED-RING POLYMER, ORGANIC THIN FILM, AND ORGANIC THIN FILM ELEMENT F12, F9, C9 ALDH1A1 2798/4885TSHR 1396/4885THRB 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.